3 Reasons SXI is Risky and 1 Stock to Buy Instead

SXI Cover Image

While the S&P 500 is up 17.4% since March 2025, Standex (currently trading at $202.09 per share) has lagged behind, posting a return of 7.2%. This may have investors wondering how to approach the situation.

Is now the time to buy Standex, or should you be careful about including it in your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Is Standex Not Exciting?

We're cautious about Standex. Here are three reasons there are better opportunities than SXI and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

A company’s long-term sales performance can indicate its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last five years, Standex grew its sales at a tepid 5.5% compounded annual growth rate. This was below our standard for the industrials sector.

Standex Quarterly Revenue

2. Recent EPS Growth Below Our Standards

While long-term earnings trends give us the big picture, we also track EPS over a shorter period because it can provide insight into an emerging theme or development for the business.

Standex’s EPS grew at an unimpressive 7.8% compounded annual growth rate over the last two years. On the bright side, this performance was higher than its 3.3% annualized revenue growth and tells us the company became more profitable on a per-share basis as it expanded.

Standex Trailing 12-Month EPS (Non-GAAP)

3. Free Cash Flow Margin Dropping

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

As you can see below, Standex’s margin dropped by 4.2 percentage points over the last five years. If its declines continue, it could signal increasing investment needs and capital intensity. Standex’s free cash flow margin for the trailing 12 months was 5.2%.

Standex Trailing 12-Month Free Cash Flow Margin

Final Judgment

Standex’s business quality ultimately falls short of our standards. With its shares underperforming the market lately, the stock trades at 23.6× forward P/E (or $202.09 per share). While this valuation is fair, the upside isn’t great compared to the potential downside. We're fairly confident there are better investments elsewhere. We’d recommend looking at the most dominant software business in the world.

High-Quality Stocks for All Market Conditions

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.